Clinical trial
Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator (PRIMARY PREVENT-VT TRIAL)
NCT06543173 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator (PRIMARY PREVENT-VT TRIAL)
- Lead sponsor
- University of Rochester
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 22, 2026
- Completion date
- August 1, 2030
- Enrollment
- 62 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.